Summary

Work experience

• director of national and international accounts - generics

  Mallinckrodt Pharmaceuticals

  2009.01-Current

  (17 years)

  OCT 22 TO PRESENT - DIRECTOR OF NATIONAL AND INTERNATIONAL ACCOUNTS – GENERICS Manage national accounts: Wholesalers, Buying Groups and Retail customers, for generics and control substances drugs. Lead pricing and contract negotiation with customer by representing the customer to internal stakeholder while advancing corporate commerical goals and strategy. Champion the planning, development, and delivery of impactful, value-added solutions by heading enterprise projects, including forming a strategic partnership with a high-value customer to secure positioning as the sole supplier of a US-made API, crafting an impactful strategy for global expansion across various geographies and products, and filing three products for Canada inclusive of product identification, pricing, and regulatory and R&D collaboration. Foster collaborative working relationships with US-based wholesalers and buying groups for domestic generic products. Monitor current and emerging market and industry trends to uncover and capitalize on key opportunities. KEY ACHIEVEMENTS Earn recognition for consistently driving YoY sales growth, directly contributing to enterprise-wide goal attainment. Assist with enterprise wide project to provide customer U.S. made product with key long term partnership and development. Negotiated and closed a commercial and distribution deal with an undisclosed company to acquire and expand capacity for distribution of commercial products across AT channels. FEB 17 TO OCT 22 - DIRECTOR OF INTERNATIONAL SALES AND ALLIANCE MANAGEMENT – GENERICS Manage distributors in 11 countries. Responsible for International Commercial Operations and P&L with $27 M in revenues. Uncover and spearhead key opportunities to grow the company’s global footprint to drive revenue generation and sustainable growth, successfully expanding presence to Canada, GCC, SEA, and South American markets. Maintain responsibility for overseeing all aspects of international commercial operations and P&L management. Entrusted with serving as the Country Manager for Canadian generic operations. Identified potential partners, negotiated contracts, and performed Due Diligence and worked with compliance and legal to ensure highest level of compliance with each partners. KEY ACHIEVEMENTS Executed strategic distribution agreements with distributors in 7 countries, including Vietnam, Saudi Arabia, the Caribbean, Singapore, Colombia, and Indonesia, while building productive and professional relationships. Led effort to launch products in Canada Negotiated the exit plans of partnerhsips and markets. OCT 2014 TO FEB 2017 - MANAGER OF BUSINESS DEVELOPMENT AND LICENSING, BRANDS AND GENERICS Spearheaded the in-depth analysis, review, and modeling of 130+ assets and companies to execute strategic deals, such as the acquisition of Ikaria and Therakos, merger with Stratatech Corp, and asset acquisition of The Medicine Company. Demonstrated a strong ability to execute sound and effective decisions in complex markets and regulatory environments. Presented data-driven insights to leadership and stakeholders for informed decision-making and strategic planning. Provided dynamic leadership to high-performing teams, including delivering training, mentorship, and support. Lead team through difficult and very short diligence processes to make key decisions and presenting them to leadership. Partnered with transition teams to optimize integration and successful launches. Performed Market research and complied forecasting KEY ACHIEVEMENTS Succeeded in directing the negotiation and closure of 11 transactional deals over a 2.5-year period. Served as Co-Lead for the divestment of Intrathecal Business to Pirimal responsible for guiding process execution, VDR, and internal communications. Determined the impact and feasibility of a $22M equity investment in Mesoblast by performing due diligence, producing forecasts and models, executing strategic negotiations, and managing communications. Demonstrated a strong ability to navigate complex regulatory environments while overseeing generics products licensing for three Intellipharmaceutics products; managed licensing deals with Fuji Pharma (Japan) and an undisclosed company. Delivered end-to-end leadership for the successful $1.3B acquisition of Therakos LLC from introduction to finalization, including pitching and achieving buy-in from the board of directors. APR 2013 TO OCT 2014 CHIEF OF STAFF TO SVP OF INTERNATIONAL COMMERCIAL OPERATIONS, BRANDS INJECTABLE Played a key role in the governance of the international commercial leadership team. Worked on transformational projects to change go-to business operations and strategies in all geographies. Drove the on-time, on-budget delivery of executive-level and international commercialization projects and initiatives by providing dynamic oversight, boosting efficiency, and ensuring alignment across global stakeholders and regions. Secured beneficial outcomes and terms for the enterprise by effectively negotiating with global partners in Asia/LATAM. KEY ACHIEVEMENTS Generated a 7% increase in operating income by pioneering the coordination and deployment of high-impact cost reduction initiatives across Europe, Latin America, and Asia. Changed business structures from direct to licensing across Asia and Middle East regions. Restructured international footprint in order to increase efficiencies and profitability. OCT 2012 TO APR 2013 - SENIOR ENGINEER, Employed strategic planning, prioritization, and needs assessment skills to spearhead engineering and infrastructure projects from initiation to delivery inclusive of resource allocation, goal setting, and cost and time management. Controlled and effectively allocated budgets up to $4.5M to ensure success and cost efficiency of multi-year initiatives. JAN 2009 TO OCT 2012 - MAINTENANCE SUPERVISOR, Supported the ongoing functionality and performance of equipment by performing preventive maintenance and repairs. Mitigated risks while working within a cGMP and highly regulated facility, ensuring adherence to DEA, FDA, OSHA, EMA, and all other applicable standards, protocols, and regulations. Coordinated and led projects related to maintenance operations.
• PORT ENGINEER/PROJECT MANAGER

  American Commercial Line

  2007.01-2009.01

  (2 years)

  PORT ENGINEER/PROJECT MANAGER.
• UTILITIES SYSTEMS OPERATOR

  Anheuser Busch Inc.

  2006.01-2007.01

  (a year)

  UTILITIES SYSTEMS OPERATOR.
• MARINE ENGINEER/MARINE OFFICER

  MEBA

  2001.01-2005.01

  (4 years)

  MARINE ENGINEER/MARINE OFFICER.

Educational experience

• United States Merchant Marine Academy, Kings Point, NY, USA

  BACHELOR OF SCIENCE (B.SC.) IN MARINE TRANSPORTATION & LOGISTICS, 2001

  1998.09-2001.07

  (3 years)